Clearthesis
Sign inSign up

Sign up free to access investment thesis for 500+ leading US stocks

AppleAppleMicrosoftMicrosoftNvidiaNvidiaAmazonAmazonAlphabetAlphabetMetaMetaTeslaTeslaBroadcomBroadcomAMDAMDTSMCTSMCArmArmQualcommQualcommMicronMicronMarvellMarvellOracleOracleAdobeAdobeSalesforceSalesforceServiceNowServiceNowCrowdStrikeCrowdStrikePalo AltoPalo AltoSpotifySpotifyCloudflareCloudflareShopifyShopifyVisaVisaMastercardMastercardRobinhoodRobinhoodCoinbaseCoinbasePalantirPalantirBerkshireBerkshireCostcoCostcoWalmartWalmartNetflixNetflixJPMorganJPMorgan
View all covered stocks →
Clearthesis
PrivacyTermsContact

© 2026 ClearThesis, Inc.

For informational purposes only. Not investment advice. ClearThesis is not a registered investment adviser.

TDOC

Teladoc HealthTDOC

$6.48
Updated Aug 18, 2026
Quality Score
1.9
Follow

Why Teladoc Health stock moved?

Updated Aug 18 at 11:32am ET.

$6.48
Loading…

What's happening with the stock

Teladoc Health fell about 1 percent today, its third straight down day, and now sits about 31 percent below its high from late July. We think this is mostly the whole market moving today, though the stock remains under pressure after recently cutting its sales outlook.

Our view

A drop this size is no fun to stomach, especially as the company struggles to grow its mental health business. We want to see if the new leadership can turn that unit around before we'd feel better about the stock, so for now, owners should just sit tight.

Read full thesis on Teladoc Health

Latest Teladoc Health updates

Follow Teladoc Health to never miss an important update.

TDOC
FilingFor the record
Aug 18

Teladoc reports a change in its leadership team

Teladoc has notified regulators of a change in its leadership team or board of directors. While the filing confirms a shift at the top, the company has not yet detailed who is departing or who will take their place.

This comes at a sensitive time for the telehealth provider. The company is currently trying to turn around its business by cutting costs and focusing more on chronic care management, such as diabetes and hypertension programs, rather than just simple video doctor visits. A change in leadership can often signal a new strategy, but it also adds uncertainty while the company is still working to reach consistent profitability.

Source: 8-K filing

TDOC
FilingFor the record
Aug 3

Mark Anquillare joins the board of directors

The company has appointed Mark Anquillare, the former president of Verisk Analytics, to its board of directors. Verisk is a firm that provides data and risk analysis to the insurance industry. This background is relevant because the company sells many of its virtual care services directly to insurance plans and large employers.

Adding an expert in insurance data may help the company better prove the value of its chronic care programs to these big buyers. This is a key part of the plan to grow its business-to-business segment, which has struggled to find momentum lately.

Source: 8-K filing

TDOC
Analyst price updateConcerning
Jul 30

Evercore ISI cuts price target to $7.50

Evercore ISI lowered its price target for the stock from $10 to $7.50 after the company cut its full-year sales outlook. The move reflects growing concern that the mental health division, BetterHelp, is shrinking faster than expected as it becomes more expensive to find new customers through online ads.

While the firm kept its neutral rating, the lower target suggests that the path to a higher stock price is blocked until the company can prove its core business-to-business segment can grow enough to offset the losses in mental health.

Source: Evercore ISI

TDOC
EarningsConcerning
Jul 29

Revenue falls 4 percent as mental health unit struggles

The company reported second-quarter revenue of about 607 million dollars, which was lower than the 620 million dollars analysts expected. The main problem was the BetterHelp mental health unit, where revenue dropped 12 percent from last year. This unit is struggling because it is costing more to acquire new patients through advertising, and demand is shifting.

Management also lowered its sales forecast for the full year to a range of 2.36 billion to 2.45 billion dollars. This is a setback for the goal of stabilizing the business. While the Integrated Care segment, which sells to employers, grew slightly, it was not enough to make up for the weakness in mental health. The stock fell about 20 percent following the news as the timeline for a recovery looks longer than it did a few months ago.

See the full quarter, and how our tracked metrics did

Source: 8-K filing

TDOC
Company newsPositive
Jul 27

Canadian virtual care program receives quality award

The company's Canadian arm received the Accreditation Canada Primer Award, which is an independent check on the safety and quality of its medical programs. This award validates that its virtual care meets the same high standards as traditional in-person medical services. While this is a small piece of the global business, maintaining these certifications is important for winning contracts with government health systems and large insurers. It helps the company stand out from smaller rivals that may not have the same level of clinical oversight.

Source: Business Wire

Teladoc Health analyst price targets

Analysts recently lowered their price targets following a flurry of legal investigations into the company. Most experts are cautious, with 15 of 42 analysts rating the stock a buy and an average target price suggesting 27% upside.

Average target$8.25+27%vs $6.48 today
TodayAvg price
Low $6High $11
Hold42 analysts
0Bearish
27Neutral
15Bullish
FirmRatingPrice TargetDate
Jefferies
Hold
$9→$8
7/30/2026
Evercore ISI
In Line
$10→$7.50
7/30/2026
Canaccord Genuity
Buy
$10→$11
7/21/2026
Evercore ISI
In Line
$5→$6
4/8/2026
Deutsche Bank
Buy
$11
3/10/2026
Stifel Nicolaus
Hold
$6
2/26/2026
Wells Fargo
Equal Weight
$6
2/26/2026
Goldman Sachs
Buy
$9→$8
1/16/2026
Goldman Sachs
Buy
$10→$9
1/9/2026
Barclays
Equal Weight
$8.50
12/8/2025
Stifel Nicolaus
Hold
$8
10/30/2025
Raymond James
—
$12→$10
7/30/2025

Teladoc Health earnings

The company has a mixed record of hitting its targets, often reporting losses even when it beats sales estimates. This makes it hard to rely on management's forecasts until they show a clearer path to profit.

Earnings history
EstimateBeatMiss
$-0.54$-0.34$-0.13Oct '24Feb '25Apr '25Jul '25Oct '25Feb '26Apr '26Jul '26nextOct '26

Teladoc Health past earnings results

ExpectedActualSurprise
EPS$-0.25$-0.21+15.9%
Revenue$615M$607M-1.4%

Key highlights

  • BetterHelp revenue sliding: BetterHelp revenue fell 12% to $212.6 million this quarter as the business struggled with a 20% drop in customers who pay out of pocket for therapy. This drop in cash paying users is a major headwind for the company, even though insurance covered revenue within the same division jumped to $21.8 million from just $2.1 million last year.
  • Integrated Care holding steady: The Integrated Care segment, which includes general medical and chronic condition services, grew its revenue by 1% to $394.3 million. This division remains the more stable part of the business, supported by chronic care enrollment that rose 14% to 1.27 million people compared to a year ago.
  • Profit margins diverging: BetterHelp adjusted EBITDA, a measure of core operating profit, plummeted 96% to $471,000 as the company spent heavily to roll out its insurance model. Meanwhile, the Integrated Care division improved its adjusted EBITDA margin to 16.5% from 14.7% a year ago, showing better efficiency in the corporate and health plan side of the business.
  • Cash flow under pressure: Free cash flow, which is the money left after running the business and paying for equipment and software, fell to $35.7 million for the quarter compared to $61.2 million a year earlier. This decline matters because it reduces the cash the company can use to pay down its $996.7 million in senior notes that are now classified as a current liability due soon.
  • Full year outlook lowered: Management expects full year revenue between $2.36 billion and $2.45 billion, which reflects a cut to its expectations for the BetterHelp segment. BetterHelp is now projected to see revenue decline as much as 19% for the year, a sharper drop than previously feared as the company shifts its focus toward users who use insurance rather than cash.

Our take: This was a difficult quarter that confirms the business is in the middle of a painful transition. The sharp drop in BetterHelp's profitability and cash pay revenue is the defining issue here, and it suggests the company's biggest growth engine is broken. While the Integrated Care side remains healthy, the ongoing struggles at BetterHelp are starting to chip away at the long-term case for the stock.

Teladoc Health’s next earnings date

Q3 2026
OCT
28
Expectation
EPS$-0.20
Revenue$591M

Metrics we are tracking

Metric
Expectations
Status
Integrated Care Members
Maintaining a base above 97 million U.S. members
100.3 million as of Q2 2026
BetterHelp Revenue Growth
Stabilizing at 0% or higher year-over-year
-12% YoY in Q2 2026
Free Cash Flow
Delivering at least $130 million for the full year
$9.4 million for the first six months of 2026
Chronic Care Enrollment
Increasing by double digits annually
14% YoY in Q2 2026

More Teladoc Health coverage from around the web

Did Teladoc Health, Inc. Insiders Breach their Fiduciary Duties to Shareholders?

PRNewsWire · Press release · Aug 17

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Teladoc Health, Inc. - TDOC

PRNewsWire · Press release · Aug 13

Securities Fraud Investigation Into Teladoc Health Inc. (TDOC) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Business Wire · Press release · Aug 6

Teladoc Health Inc. (TDOC) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

Business Wire · Press release · Aug 6

Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Teladoc Health (TDOC)

GlobeNewsWire · Press release · Aug 5

Teladoc Health Appoints Financial Executive Mark Anquillare to Its Board of Directors

Globe News Wire · Press release · Aug 3

Stay on top of Teladoc Health

Follow Teladoc Health to get the latest and most important updates.

Follow TDOC

On this page

Full thesisFollow TDOC